drug-treatment-central-venous-catheter-mouse-model-angiotensin-ii

Drug Treatment by Central Venous Catheter in a Mouse Model of Angiotensin II Induced Abdominal Aortic Aneurysm and Monitoring by 3D Ultrasound

Since pharmaceutical treatment options are lacking in the clinical management of abdominal aortic aneurysm (AAA), animal models, in particular mouse ...

Medical University of Vienna and Vienna General Hospital

The maximal aortic diameter is currently the only clinically applied predictor of abdominal aortic aneurysm (AAA) progression. It is known that the risk of rupture is associated with aneurysm size; hence, accurate monitoring of AAA expansion is crucial. Aneurysmal vessel wall calcification and its implication on AAA expansion are insufficiently explored. We evaluated the vascular calcification using longitudinal computed tomography angiographies (CTA) of patients with an AAA and its association with AAA growth.

Wolf Eilenberg

Division of Vascular Surgery,
Department of General Surgery,
Division of Vascular Surgery, Department of General Surgery

Medical University of Vienna and Vienna General Hospital

Drug Treatment by Central Venous Catheter in a Mouse Model of Angiotensin II Induced Abdominal Aortic Aneurysm and Monitoring by 3D Ultrasound

Wolf Eilenberg

.css-o250i3{font-size:18px;font-family:Open Sans,sans-serif;line-height:21.6px;}Division of Vascular Surgery,Department of General Surgery,Division of Vascular Surgery, Department of General Surgery

Medical University of Vienna and Vienna General Hospital

Drug Treatment by Central Venous Catheter in a Mouse Model of Angiotensin II Induced Abdominal Aortic Aneurysm and Monitoring by 3D Ultrasound

Division of Vascular Surgery,
Department of General Surgery,
Division of Vascular Surgery, Department of General Surgery